SAFETY GUIDELINES FOR PRION DISEASES


	SAFETY GUIDELINES FOR PRION DISEASES Daron Davis¹, Ruth Carrico², Joseph C Parker³ 1 University of Kentucky Medical Center, ²Infection Control, University of Louisville Hospital, ³ Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine Inclusion body myositis (IBM) Although PrP (prion proteins) have been described in IBM, no progressive transmissible spongiform encephalopathy has been documented. The significance of this finding is not yet apparent. REFERENCES: 1. Carpenter S: J Neuropath Exp Neurol 55, 1105, 1996 2. Askanas V et al: Neuro Report 5, 25, 1993 3. Sarkozi E et al: Am J Pathol 145, 1280, 1994 /td>

SAFETY GUIDELINES FOR PRION DISEASES

Daron Davis¹, Ruth Carrico², Joseph C Parker³

1 University of Kentucky Medical Center, ²Infection Control, University of Louisville Hospital, ³ Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine

Inclusion body myositis (IBM)

Although PrP (prion proteins) have been described in IBM, no progressive transmissible spongiform encephalopathy has been documented. The significance of this finding is not yet apparent.

REFERENCES:

1. Carpenter S: J Neuropath Exp Neurol 55, 1105, 1996
2. Askanas V et al: Neuro Report 5, 25, 1993
3. Sarkozi E et al: Am J Pathol 145, 1280, 1994 /td>